Co-Authors
This is a "connection" page, showing publications co-authored by Cornelis Vlaar and Jorge Duconge.
Connection Strength
0.846
-
Mart?nez-Jim?nez JE, Sathisaran I, Reyes Figueroa F, Reyes S, L?pez-Nieves M, Vlaar CP, Monbaliu JM, Roma?ach R, Rua?o G, Stelzer T, Duconge J. A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities. Int J Pharm. 2025 Feb 10; 670:125070.
Score: 0.225
-
Reyes-Gonz?lez S, de Las Barreras C, Reynaldo G, Rodr?guez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans. Drug Metab Pers Ther. 2020 Aug 19.
Score: 0.167
-
Reyes-Gonz?lez S, de Las Barreras C, Reynaldo G, Rodr?guez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans. Drug Metab Pers Ther. 2020 08 18; 35(4).
Score: 0.167
-
Grafals-Ruiz N, Medina JI, Colon Gonzalez J, Torres-Sanchez A, Martin-Ortiz KM, Vlaar CP, Duconge J, Rodriguez-Orengo J, Dharmawardhane S. M6 metabolite contributes to the efficacy of the Rac/Cdc42 inhibitor MBQ-167 in metastatic breast cancer. Mol Cancer Ther. 2026 Mar 05.
Score: 0.061
-
Mbodji A, Cruz KM, G?mez AA, Vlaar CP, Duconge J, Monbaliu JM, Cersonsky RK, Yu L, Zhang GG, Coquerel G, Roma?ach RJ, Stelzer T. Controlled API crystallization during additive manufacturing of solid dosage form for flexible integrated pharmaceutical manufacturing. Int J Pharm. 2025 Nov 30; 685:126197.
Score: 0.059
-
Rodr?guez-Fern?ndez K, Reynaldo-Fern?ndez G, Reyes-Gonz?lez S, de Las Barreras C, Rodr?guez-Vera L, Vlaar C, Monbaliu JM, Stelzer T, Duconge J, Mangas-Sanjuan V. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomed Pharmacother. 2024 Jan; 170:115977.
Score: 0.052
-
Cruz-Collazo A, Ruiz-Calderon JF, Picon H, Borrero-Garcia LD, Lopez I, Castillo-Pichardo L, Del Mar Maldonado M, Duconge J, Medina JI, Bayro MJ, Hern?ndez-O'Farrill E, Vlaar CP, Dharmawardhane S. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer. Mol Cancer Ther. 2021 12; 20(12):2420-2432.
Score: 0.045
-
Maldonado MDM, Rosado-Gonz?lez G, Bloom J, Duconge J, Ruiz-Calder?n JF, Hern?ndez-O'Farrill E, Vlaar C, Rodr?guez-Orengo JF, Dharmawardhane S. Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography-Tandem Mass Spectrometry. ACS Omega. 2019 Nov 05; 4(19):17981-17989.
Score: 0.039
-
Humphries-Bickley T, Castillo-Pichardo L, Corujo-Carro F, Duconge J, Hernandez-O'Farrill E, Vlaar C, Rodriguez-Orengo JF, Cubano L, Dharmawardhane S. Pharmacokinetics of Rac inhibitor EHop-016 in mice by ultra-performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Feb 15; 981-982:19-26.
Score: 0.028